Literature DB >> 21321074

Analysis of murine genetic predisposition to pneumococcal infection reveals a critical role of alveolar macrophages in maintaining the sterility of the lower respiratory tract.

Keer Sun1, Yan Gan, Dennis W Metzger.   

Abstract

The study of pathogenic mechanisms of disease can be greatly facilitated by studying genetic differences in susceptibility to infection. In the present study, we compared the severity of pneumococcal infection in C57BL/6 (B6) and 129Sv mice. The results showed that 129Sv mice were remarkably more susceptible to pneumococcal infection than B6 mice. Bacterial clearance, proinflammatory mediators, leukocyte recruitment, and phagocyte activities were measured to examine potential immune factors associated with differences in susceptibility to pneumococcal infection. The greater susceptibility of 129Sv mice was associated only with inadequate alveolar macrophage bacterial killing, as indicated by significantly decreased initial bacterial clearance from the respiratory tract. Effective pneumococcal clearance was not dependent upon Toll-like receptor 2 (TLR2) expression, oxidative stress, or matrix metallopeptidase 12 (MMP-12) expression. Furthermore, phagocytosis analysis suggested that the deficiency found in 129Sv alveolar macrophages was not due to a lack of bacterial recognition but, rather, to reduced bacterial uptake. In conclusion, our findings indicate a crucial role of alveolar macrophage phagocytosis during innate defense against pneumococcal infection, which may explain the association of host genetic risk factors with predisposition to pneumococcal infection.

Entities:  

Mesh:

Year:  2011        PMID: 21321074      PMCID: PMC3088159          DOI: 10.1128/IAI.01143-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  Virulence factors and the pathogenesis of disease caused by Streptococcus pneumoniae.

Authors:  T J Mitchell
Journal:  Res Microbiol       Date:  2000 Jul-Aug       Impact factor: 3.992

2.  Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection.

Authors:  David H Dockrell; Helen M Marriott; Lynne R Prince; Victoria C Ridger; Paul G Ince; Paul G Hellewell; Moira K B Whyte
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

3.  A major locus conferring susceptibility to infection by Streptococcus pneumoniae in mice.

Authors:  Paul Denny; Elaine Hopes; Neill Gingles; Karl W Broman; William McPheat; John Morten; Janet Alexander; Peter W Andrew; Steve D M Brown
Journal:  Mamm Genome       Date:  2003-07       Impact factor: 2.957

4.  Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia.

Authors:  Sylvia Knapp; Jaklien C Leemans; Sandrine Florquin; Judith Branger; Nico A Maris; Jennie Pater; Nico van Rooijen; Tom van der Poll
Journal:  Am J Respir Crit Care Med       Date:  2002-09-25       Impact factor: 21.405

5.  Characterization of a Staphylococcus aureus surface virulence factor that promotes resistance to oxidative killing and infectious endocarditis.

Authors:  Natalia Malachowa; Petra L Kohler; Patrick M Schlievert; Olivia N Chuang; Gary M Dunny; Scott D Kobayashi; Jacek Miedzobrodzki; Gregory A Bohach; Keun Seok Seo
Journal:  Infect Immun       Date:  2010-10-11       Impact factor: 3.441

6.  Differential activation of the immune system by virulent Streptococcus pneumoniae strains determines recovery or death of the host.

Authors:  Y Mizrachi-Nebenzahl; S Lifshitz; R Teitelbaum; S Novick; A Levi; D Benharroch; E Ling; R Dagan
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

7.  Genetic background affects susceptibility in nonfatal pneumococcal bronchopneumonia.

Authors:  J A Preston; K W Beagley; P G Gibson; P M Hansbro
Journal:  Eur Respir J       Date:  2004-02       Impact factor: 16.671

8.  Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene.

Authors:  Sandra H Burnett; Edward J Kershen; Jiayou Zhang; Li Zeng; Susan C Straley; Alan M Kaplan; Donald A Cohen
Journal:  J Leukoc Biol       Date:  2004-01-14       Impact factor: 4.962

9.  Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae.

Authors:  Alison R Kerr; Xiao-Qing Wei; Peter W Andrew; Tim J Mitchell
Journal:  Microb Pathog       Date:  2004-06       Impact factor: 3.738

10.  Oxidative stress triggers thiol oxidation in the glyceraldehyde-3-phosphate dehydrogenase of Staphylococcus aureus.

Authors:  Harald Weber; Susanne Engelmann; Dörte Becher; Michael Hecker
Journal:  Mol Microbiol       Date:  2004-04       Impact factor: 3.501

View more
  12 in total

1.  Influenza infection suppresses NADPH oxidase-dependent phagocytic bacterial clearance and enhances susceptibility to secondary methicillin-resistant Staphylococcus aureus infection.

Authors:  Keer Sun; Dennis W Metzger
Journal:  J Immunol       Date:  2014-02-21       Impact factor: 5.422

2.  Role of copper efflux in pneumococcal pathogenesis and resistance to macrophage-mediated immune clearance.

Authors:  Michael D L Johnson; Thomas E Kehl-Fie; Roger Klein; Jacqueline Kelly; Corinna Burnham; Beth Mann; Jason W Rosch
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

3.  Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation.

Authors:  Niharika Sharma-Chawla; Vicky Sender; Olivia Kershaw; Achim D Gruber; Julia Volckmar; Birgitta Henriques-Normark; Sabine Stegemann-Koniszewski; Dunja Bruder
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

4.  Outbred ICR/CD1 mice display more severe neuroinflammation mediated by microglial TLR4/CD14 activation than inbred C57Bl/6 mice.

Authors:  M Nikodemova; J J Watters
Journal:  Neuroscience       Date:  2011-06-13       Impact factor: 3.590

5.  Allergic Lung Inflammation Reduces Tissue Invasion and Enhances Survival from Pulmonary Pneumococcal Infection in Mice, Which Correlates with Increased Expression of Transforming Growth Factor β1 and SiglecF(low) Alveolar Macrophages.

Authors:  Alan M Sanfilippo; Yoichi Furuya; Sean Roberts; Sharon L Salmon; Dennis W Metzger
Journal:  Infect Immun       Date:  2015-05-11       Impact factor: 3.441

6.  Harvesting murine alveolar macrophages and evaluating cellular activation induced by polyanhydride nanoparticles.

Authors:  Ana V Chavez-Santoscoy; Lucas M Huntimer; Amanda E Ramer-Tait; Michael Wannemuehler; Balaji Narasimhan
Journal:  J Vis Exp       Date:  2012-06-08       Impact factor: 1.355

7.  Importance of bacterial replication and alveolar macrophage-independent clearance mechanisms during early lung infection with Streptococcus pneumoniae.

Authors:  Emilie Camberlein; Jonathan M Cohen; Ricardo José; Catherine J Hyams; Robin Callard; Suneeta Chimalapati; Jose Yuste; Lindsey A Edwards; Helina Marshall; Nico van Rooijen; Mahdad Noursadeghi; Jeremy S Brown
Journal:  Infect Immun       Date:  2015-01-12       Impact factor: 3.441

8.  Allergic Airway Disease Prevents Lethal Synergy of Influenza A Virus-Streptococcus pneumoniae Coinfection.

Authors:  Sean Roberts; Sharon L Salmon; Donald J Steiner; Clare M Williams; Dennis W Metzger; Yoichi Furuya
Journal:  mBio       Date:  2019-07-02       Impact factor: 7.867

9.  Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung.

Authors:  Adam K A Wright; Mathieu Bangert; Jenna F Gritzfeld; Daniela M Ferreira; Kondwani C Jambo; Angela D Wright; Andrea M Collins; Stephen B Gordon
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

10.  Genetic factors regulating lung vasculature and immune cell functions associate with resistance to pneumococcal infection.

Authors:  Magda S Jonczyk; Michelle Simon; Saumya Kumar; Vitor E Fernandes; Nicolas Sylvius; Ann-Marie Mallon; Paul Denny; Peter W Andrew
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.